Early-Onset Colorectal Cancer: New Risk Factors or More of the Same at Earlier Ages?
2/5 보강
OpenAlex 토픽 ·
Colorectal Cancer Screening and Detection
Birth, Development, and Health
Genetic factors in colorectal cancer
Rates of colorectal cancer diagnosed before age 50 (early-onset colorectal cancer) are increasing in many countries.
APA
Darren R. Brenner (2026). Early-Onset Colorectal Cancer: New Risk Factors or More of the Same at Earlier Ages?. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 35(4), 494-496. https://doi.org/10.1158/1055-9965.EPI-25-1705
MLA
Darren R. Brenner. "Early-Onset Colorectal Cancer: New Risk Factors or More of the Same at Earlier Ages?." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 35, no. 4, 2026, pp. 494-496.
PMID
41918362 ↗
Abstract 한글 요약
Rates of colorectal cancer diagnosed before age 50 (early-onset colorectal cancer) are increasing in many countries. Many regions have lowered the age of screening initiation to 45 in response. Although early studies suggest increases in early cancer detection and improved outcomes among newly eligible individuals, some of the fastest increases are among those below 45, particularly for rectal cancers. In those below 45, population-wide screening is not likely to be cost-effective. Research to understand the factors driving the increases is essential in these younger groups. Recent data suggest that both novel and known exposures play a role. Novel initiators such as colibactin-producing Escherichia coli have been identified, and known promoters such as obesity, poor diet, and inactivity, among others, are increasing in prevalence among younger generations. Data from Baek and colleagues reinforce the role of metabolic and lifestyle factors, with differences observed between sexes. Their findings support the concept that early exposure to known promoters increases the risk of carcinogenesis. Future studies that incorporate biomarkers along with purposefully collected early-life data will be integral to identifying causal exposures and informing targeted cancer prevention strategies. See related article by Baek et al., p. 647.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.